- This event has passed.
Codex DNA webinar: Development of a replicon RNA vaccine platform for response to emerging variants of SARS-CoV-2
May 5 @ 17:00 - 18:00
The global COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus created an urgent need for protective interventions. Fortunately, new advances in vaccine development, including nucleic acid-based approaches, have enabled the unprecedented rollout of multiple vaccine products within a year from the onset of the pandemic.
However, SARS-CoV-2 continues to evolve, and new viral variants harboring mutations appear to enable escape from antibody neutralization. Multiple approaches will likely be required to combat these threats as the scientific and pharmaceutical communities continue to develop anti-SARS-CoV-2 therapeutics and vaccines.
Join Codex DNA as Dr. Jesse Erasmus from the University of Washington School of Medicine discusses his approach to addressing these emergent challenges. In the webinar, you will learn how Dr. Erasmus mitigated key design and discovery hurdles to designing a framework for the scalable manufacturing and improved stability required for global vaccine distribution.
Dr. Erasmus will further discuss his development of a two-vialed replicating RNA (repRNA) vaccine and Lipid InOrganic Nanoparticle (LION) platform that can be mixed immediately prior to injection.
Jesse Erasmus, PhD. is an Acting Assistant Professor at the University of Washington School of Medicine and the Director of Virology at HDT Bio. His research focuses on studying virus-derived mechanisms of gene expression for the development of new RNA vaccine and therapeutic technologies.